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Abstract  
 
Background: The continuous search for new lead compounds as viable inhibitors of specific enzymes linked to 
carbohydrate metabolism has intensified. Cyperus esculentus L. is one of the therapeutically implicated botanicals against 
several degenerative diseases including diabetes mellitus.  
Materials and Methods: This study evaluated the antioxidant and mechanism(s) of inhibitory potential of aqueous extract 
of C. esculentus on α-amylase and α-glucosidase in vitro. The extract was investigated for its radical scavenging and 
hypoglycaemic potentials using standard experimental procedures. Lineweaver-Burke plot was used to predict the manner 
in which the enzymes were inhibited.  
Results: The data obtained revealed that the extract moderately and potently inhibited the specific activities of α-amylase 
and α-glucosidase, respectively. The inhibition was concentration-related with respective IC50 values of 5.19 and 0.78 
mg/mL relative to that of the control (3.72 and 3.55 mg/mL). The extract also significantly scavenged free radicals and the 
effects elicited could be ascribed to its phytoconstituents.  
Conclusion: The respective competitive and non-competitive mode of action of the extract is due to its inhibitory potentials 
on the activities of α-amylase and α-glucosidase. Going forward, in addition to completely characterize the exact 
compound(s) responsible for the elicited activity in this study, pertinent attention will be given to the in vivo evaluation of 
the identified constituents. 
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Introduction 
 
Tiger nut or Cyperus esculentus L. (Cyperaceae) is widely cultivated and used as dietary supplement in the 
Arabian Peninsula, Spain, east Africa, and many West African countries including Nigeria (Abaejoh et al., 2006). It is an 
erect fibrous-rooted perennial plant, 1 to 3 ft tall and reproduces by seeds and rhizomes (Belewu and Abodunrin, 2006). 
The tubers of C. esculentus (CE) are edible with characteristic sweet nutty flavor. In Nigeria, the fresh tuber is either 
roasted, baked, dried, eaten raw or prepared as ‘kunnu’ (Oladele and Aina, 2007). Its fat composition is similar to that of 
olive plant with 72% unsaturated (oleic acid and linoleic acid) and 28% saturated (palmitic acid and stearic acid) fatty acids 
(Zhang et al., 1996). CE is also rich in phosphorus and potassium (Belewu and Belewu, 2007). Extracts of CE have been 
used as anti-cancer, anti-microbial, anti-diarrhoea, anti-flatulence as well as in the treatment of anaemia, urinary tract 
infections and hypercholesterolemia (Chevallier, 1996; Martinez, 2003; Mohammed et al., 2005; Borges et al., 2008; 
Adejuyitan et al., 2009; Anderson et al., 2009). Previous reports also revealed CE to be non-toxic, practically safe, and with 
significant aphrodisiac properties (Ajani et al., 2016; Sabiu et al., 2016a). 
Diabetes mellitus (DM) is a metabolic disorder with significant impact on the well-being and quality of life of 
humans. The disease is significantly emerging as one of the greatest heath challenges to human (Vasim et al., 2012). The 
global incidence of DM revealed an estimated 171 million people as victims of the disease in 2000, and it has been 
projected that the prevalence will increase to 366 million by 2030 if no practicable and sustainable intervention is adopted 
(Wild et al., 2004). A more recent report on its global prevalence has predicted an increase in this figure, pegging it at well 
above 438 million by 2030 (Colagiuri, 2010). With this prediction, someone dies from its complications every 10 sec and 1 
in every 5 persons may be gravely affected. In sub-Saharan Africa, DM is also an important emerging disease presenting 
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South Africa as the most affected with a prevalence of 8.3% and closely followed by Nigeria (4.5%) (IDF, 2014). This 
exponential increase in the prevalence of DM may be either due to changes in diet (highly refined diets), aging and lifestyle 
of the people (reduced physical activity, urbanization etc.) or ravaging effect of free radicals (Wild et al., 2004). While 
orthodox interventions have been embraced and have proved to be effective in the treatment of DM, affordability, 
sensitivity and side effects have undermined their uses (Campbell et al., 1996). Interestingly, the management of diabetes 
via natural sources (as probable alternative) has been achieved either by inhibiting free radical events or/and inhibition of 
key enzymes (𝛼-amylase and 𝛼-glucosidase) involved in starch digestion (Sabiu and Ashafa, 2016). The incidence of DM is 
closely linked with increased free radical formation and malfunctioning antioxidant defense systems (Maritim et al., 2003). 
Additionally, the occurrence of oxidative stress is a crucial event in both the diabetogenic process and its 
secondary complications (Lipinski, 2001). In light of these, antioxidant-rich sources could serve a good dietary intervention 
in the management of the disease. Besides being rich in antioxidant vitamins and minerals (Belewu and Belewu, 2007) and 
its flour routinely recommended as one of the dietary control options for the diabetic patients, extracts from CE have been 
used to treat and manage diabetes (Salwa et al., 2010). However, there is information gap on the tentative mechanism for 
the use of the extract to treat such debilitating ailment. This study, therefore investigated the appropriateness of CE extract 
as a dietary alternative for the management of DM by evaluating its 𝛼-amylase and 𝛼-glucosidase inhibitory activities. The 
antioxidant property of CEE was also determined. 
 
Materials and Methods 
Chemicals and reagents 
 
Acarbose was procured from Bayer Medical Co., Germany. While porcine pancreatic α-amylase, rat intestine 
acetone powder (RIAP), p-nitrophenyl-α-D-glucopyranoside (pNPG), sodium dodecyl sulphate (SDS), silymarin and 1,1-
diphenyl-2-picryl-hydrazyl (DPPH) were purchased from Sigma Chemical Co., St. Louis, Missouri, USA, soluble starch 
and dinitrosalicylic acid (DNS) were products of J. T. Baker Inc., Phillipsburg, USA. Water used was glass-distilled and 
other chemicals were of analytical grade. 
 
Plant collection, extract preparation and phytochemicals quantification 
 
Fresh tubers of CE were collected from the Ilorin metropolis Emir’s market, Nigeria and were authenticated at 
Plant Sciences Department, University of Ilorin, Ilorin, Nigeria. A voucher specimen (UIH001/21781) was subsequently 
deposited at the Herbarium of the University. The tubers were rinsed under running tap, oven-dried (370C, 48 h) and 
powdered (model MS-223; Blender/Miller III, Taiwan, China). A portion (200 g) of the powdered material was agitatedly 
extracted in distilled water (3 L) for 24 h. The infusion was subjected to filtration (Whatman no. 1 filter paper) and the 
filtrate obtained concentrated to a yield of 36.25 g CE extract (CEE) that was kept air-tight and refrigerated (-40C) prior to 
use.  
Following standard procedures (Harbone, 1973; Obadoni and Ochuko, 2001; Achana et al., 2005), the initially 
detected phytonutrients (alkaloids, saponins and tannins) from CEE (Ekeanyawu et al., 2010) were quantified. 
 
 In vitro antioxidant assays 
DPPH radical inhibition 
 
The DPPH radical scavenging effect of CEE was evaluated as previously described (Turkoglu et al., 2007). In 
brief, 1 mL of varying methanolic concentrations (0.2-1.0 mg/mL) of the CEE or silymarin (standard) was added to 1 mL 
of 0.2 mM methanolic solution of DPPH. Similarly, sterile distilled water (1 mL) was mixed with an aliquot (1 mL) of 0.2 
mM methanolic DPPH and used as control. Following an incubation period of 30 min at room temperature in each case, the 
absorbance was read against blank at 516 nm using a spectrophotometer (Beckman, DU 7400, USA). The inhibitory ability 
(I%) of CEE on DPPH radical was estimated as: 
I% = [(Acontrol – Atest)/Acontrol] × 100,  
where Acontrol = absorbance of the control, Atest = absorbance of the test sample. Thereafter, the concentration of CEE 
producing 50% inhibitory (IC50) effect on the DPPH radical was calculated from a standard curve.  
  
Hydrogen peroxide inhibition 
 
The adapted procedure of Ruch et al. (1989) was used in this assay. In brief, 0.6 mL H2O2 (40 mM) was mixed 
with 3.4 mL of phosphate buffered (pH 7.4) solution of 0.2-1.0 mg/mL concentrations of either CEE or silymarin and 
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incubated (250C, 10 min). The extract was replaced with distilled water for the control sample and the absorbance in each 
case was spectrophotometrically read (230 nm). The H2O2 inhibitory potential of CEE was thereafter calculated using:  
% H2O2 scavenged = [Acontrol -(Atest – Asample)/Acontrol] × 100, Acontrol is the absorbance of the control. Atest and Asample 
represent the absorbance of the mixture with the extract and that of the extract alone, respectively. The IC50 value was 
thereafter estimated from the calibration curve. 
 
Hydroxyl radical (OH*) inhibition 
 
The OH* inhibitory effect of CEE was determined as earlier reported (Smirnoff and Cumbes, 1996). In brief, 2 mL 
of the extract or silymarin (at 0.2-1.0 mg/mL) were mixed with 0.6 mL of ferrous sulfate (8 mM), 0.5 mL of H2O2 (20 mM) 
and 2 mL of salicylic acid (3 mM). After 30 min of incubation (37oC), distilled water (0.9 mL) was added and the resulting 
mixture centrifuged (Beckman and Hirsch, Burlington, IO, USA) at 4,472 g for 10 min. For the control, sterile distilled 
water was used. The absorbance in each case was read at 510 nm and the IC50 value was calculated subsequent to 
determination of inhibitory capacity of CEE against OH* using the expression:  
% hydroxyl radical scavenged = [Acontrol –(Atest – Asample)/Acontrol] × 100, Acontrol, Atest and Asample represent the absorbance of 
the control, mixture with the extract and that of the extract alone, respectively. 
 
Lipid peroxidation assay 
 
The capability of CEE to halt generation of lipid peroxide in an egg yolk homogenate was adapted in this assay 
(Oyedemi et al., 2012). Exactly 0.5 mL (10% in distilled water) of the yolk homogenate was mixed with different 
concentrations (0.1 mL) of either CEE or silymarin in different sets of tubes. Following making the mixture up to 1 mL 
with distilled water, 0.07 M Ferrous sulphate solution (0.05 mL) was introduced and incubated (60°C, 30 min) to enhance 
peroxidation. This was followed by the addition of 0.05 mL of 20% trichloroacetic acid and 1.5 mL each of acetic acid 
(20%) and 0.8% thiobarbituric acid (in 1.1 % w/v SDS). The resulting solution was boiled (100°C, 1 h). After cooling 
(25°C), n-butanol (5.0 mL) was introduced and centrifuged (3000 rpm, 10 min). While sterile distilled water replaced the 
extract as blank, the absorbance of the supernatant was then spectrophotometrically (Beckman, DU 7400, USA) read (532 
nm).  
 
In vitro antidiabetic assays 
Kinetics of α-amylase inhibition 
 
This was achieved following reported methods (Elsnoussi et al., 2012; Sabiu et al., 2016b). Briefly, known 
concentrations (0.25-10.0 mg/mL) of the extract or acarbose (standard) were prepared and 500 µL of each was mixed with 
500 µL of 0.02 M sodium phosphate buffer (pH 6.9) containing 0.5 mg/mL of ice cold porcine pancreatic α-amylase 
solution in test tubes. The reaction mixtures were then incubated (25ºC, 10 min). Subsequently, 500 µL of 1% starch 
solution in 0.02 M sodium phosphate buffer (pH 6.9) was introduced into each tube. The mixtures were further incubated 
(25ºC, 10 min) prior to 1.0 mL addition of DNS colour reagent to halt the reaction. The tubes were then heated (100 ºC, 5 
min), completely cooled (25 ºC) and the diluted (sterile distilled water, 15 mL) prior to absorbance reading (540 nm) 
(Beckman, DU 7400, USA). The control contained the buffer (500 µL) instead of the extract. The experiments were 
conducted in triplicate and the α-amylase inhibitory potential of CEE was then calculated and expressed as percentage: 
 
% Inhibition = [(∆Acontrol – ∆Aextract)/ ∆Acontrol] × 100,  
 
where  ∆Aextract and ∆Acontrol are the respective changes in absorbance of the extract sample and control. The IC50 of CEE 
against α-amylase activity was thereafter calculated from a standard calibration plot. 
Subsequently, 100 µL of either the extract (at it IC50) or sodium phosphate buffer (pH 6.9, 0.02 M) was pre-
incubated (25ºC, 10 min) with α-amylase solution (100 μL) in two sets of test tubes. Following this, varying concentrations 
(0.3-5.0 mg/mL) of starch (substrate (S)) was added to both sets of mixtures to initiate the reaction. Finally, the resulting 
mixture in each case was further treated with DNS (100 μL), boiled (100 ºC, 5 min) and allowed to proceed as highlighted 
above. The released reducing sugar was then spectrophotometrically (Beckman, DU 7400, USA) estimated from maltose 
standard curve. The values obtained were expressed as reaction rates (v). Using Lineweaver-Burk double reciprocal plot 
(Lineweaver and Burk, 1934), the kinetic indices (Km and Vmax values) and the tentative mechanism of inhibitory effect 
of CEE on the activity of α-amylase was predicted. 
 
 
Sabiu et al., Afr J Tradit Complement Altern Med., (2017) 14 (4): 46-53 
https://doi.org/10.21010/ajtcam.v14i4.6 
 
49 
 
Kinetics of α-glucosidase inhibition 
 
The adapted method of Oki et al. (1999) was used to prepare α-glucosidase solution from RIAP. Briefly, the RIAP 
(25 mg/mL) was homogenized (ice-cold 50 mM phosphate buffer), centrifuged (6000 × g, 15 min) and the resulting clear 
supernatant was used as the enzyme solution for determination of the specific activity of α-glucosidase. However, for the 
inhibitory effect of the extract on the activity of the enzyme, the procedure of Elsnoussi et al. (2012) was used. Briefly, 
different concentration (0.25-10.0 mg/mL) of the extract or acarbose were prepared and 50 µL from each stock solution was 
mixed with 100 µL of 0.1 M phosphate buffer (pH 6.9) containing 1.0 M of α-glucosidase solution and incubated in 96-well 
plates at 25ºC for 10 min. Following this, 50 µL of 5 mM pNPG solution in 0.1 M phosphate buffer (pH 6.9) was added to 
each well and the reaction mixtures were further incubated at 25ºC for 5 min. The absorbance in each case was read at 405 
nm using a micro-plate reader (Thermomax, USA) and the values compared with a control which contained 50 µL of the 
buffer instead of the extract. The assay was triplicated and the inhibitory effect of the extract on the activity of α-
glucosidase was calculated. Using standard calibration curve, the concentration of the extract causing 50% inhibition (IC50) 
of α-glucosidase activity was extrapolated. 
To further determine the inhibitory kinetics of the extract against the specific activity of α-glucosidase, 50 μL of 
the extract (at its IC50) was pre-incubated (25°C, 10 min) with 100 μL of α-glucosidase solution in a set of tubes. In separate 
set of tubes, the α-glucosidase solution was similarly pre-incubated with phosphate buffer (pH 6.9, 50 μL). Subsequently, 
50 µL of pNPG (0.63 – 2.0 mg/mL) was added to both sets of mixtures to initiate the reaction. The reaction mixture was 
then incubated (25°C, 10 min), and 500 µL of Na2CO3 was added to stop the reaction. The released sugar in each case was 
colorimetrically estimated using a p-nitrophenol calibration curve. Rates of reaction (v) were then estimated and 
Lineweaver-Burk double reciprocal plot was used to predict the nature of inhibition of the enzyme by CEE.  
 
Data computation 
 
Results were subjected to one-way analysis of variance (ANOVA) using SPSS software package for windows 
(Version 16, SPSS Inc., Chicago, USA) and expressed as mean ± standard error of mean (SEM) of replicate determinations. 
Using Duncan’s Multiple Range Test, significantly different means was considered at 95% confidence level.  
 
Results  
Quantified phytoconstituents and antioxidant activity 
 
Data on the quantified phytoconstituents of the CEE revealed that it is composed of 17.65 ± 0.25, 29.32 ± 0.12, 
and 10.38 ± 0.25% w/w of alkaloids, saponins and tannins, respectively (Table 1). 
Table 1: Quantitative phytochemical constituents of C. esculentus aqueous extract 
Phytochemical Alkaloids Saponins Tannins 
Composition (% w/w) 17.65 ± 0.25 29.32 ± 0.12 10.38 ± 0.25 
 
The result of the in vitro antioxidant potential of the extract is presented in Table 2. The extract dose dependently 
inhibited and scavenged the formed radicals with significant effect exhibited against the DPPH radical judging by the IC50 
value (0.25 mg/mL) when compared with silymarin (0.82 mg/mL). Similarly, compared with the standard (silymarin, IC50 
0.67 mg/mL), the CEE (IC50 0.27 mg/mL) remarkably scavenged H2O2 radical. For the OH and lipid peroxidized radicals, 
the extract also displayed significant radical scavenging effect (IC50 0.75 and 0.45 mg/mL, respectively) and competed 
favorably with silymarin (0.71 and 0.50 mg/mL). The coefficient of determination (R2) values in each case is also presented 
(Table 2). 
 
Table 2: Antioxidant properties of C. esculentus aqueous extract. 
 
Treatment  
DPPH H2O2 OH* LPO* 
IC50(mg/mL) R2 IC50(mg/mL) R2 IC50(mg/mL) R2 IC50(mg/mL) R2 
CEE 0.25 0.9759 0.27 0.9123 0.75 0.8865 0.45 0.9936 
Silymarin 0.82 0.8976 0.67 0.9345 0.71 0.9668 0.50 0.9211 
CEE=Cyperus esculentus aqueous extract 
 
In vitro enzyme kinetics inhibitory potentials 
 
The data obtained with respect to the inhibitory potential of the CEE on the specific activities of α-amylase and α-
glucosidase revealing dose-related effect are shown in Table 3. While the inhibitory effect of the extract against α-amylase 
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was significantly (p<0.05) different from that elicited by acarbose (reference drug) at higher doses (5.0-10.0 mg/mL), the 
lower doses revealed non-significant (p>0.05) influence. The IC50 values for CEE (5.19 mg/mL) and acarbose (3.72 
mg/mL) were also significantly (p<0.05) different (Table 3). Investigation into the mechanism of action of the CEE on the 
enzyme revealed that the enzyme was competitively inhibited (Fig. 1). The respective Km values for the control and CEE 
were 0.002 and 0.003 mg, while the Vmax was 0.05 μM/min. Contrary to the observation on the α-amylase, the CEE 
significantly (p<0.05) inhibited the activity of α-glucosidase at the lower (0.25-2.50 mg/mL) and highest (10.0 mg/mL) 
investigated concentrations, with the highest dose eliciting the best and most prominent effect relative to the control. This 
was further supported by the lower IC50 value (0.78 mg/mL) for the extract when compared with acarbose (3.55 mg/mL) 
(Table 3). The kinetics evaluation of the tentative mode of inhibition of α-glucosidase showed that the enzyme was 
independently inhibited by the extract. The reciprocal plot showed a decrease in both Vmax and Km values for the extract 
(0.02 μM/min, 0.0006 mg) relative to the control (0.05 μM/min, 0.0015 mg), thereby indicating an uncompetitive mode of 
inhibition (Fig. 2). 
 
 
Table 3: Inhibitory potential of C. esculentus aqueous extract on the activities of α-amylase and α-glucosidase (n = 3, mean 
± SEM). 
 
Concentration (mg/mL) 
% inhibition 
α-amylase α-glucosidase 
Acarbose Extract Acarbose Extract 
0.25 18.05 ± 0.05 17.90 ± 0.12 22.01 ± 0.11  39.55 ± 0.09# 
0.50 22.90 ± 0.07 21.88 ± 0.18 38.02 ± 0.13  53.21 ± 0.10# 
2.50 48.09 ± 0.10 48.10 ± 0.06 43.22 ± 0.05 60.22 ± 0.12# 
5.00 69.11 ± 0.20 54.01 ± 0.05# 70.28 ± 0.12 73.01 ± 0.14 
10.0 88.27 ± 0.11 69.31 ± 0.13# 79.19 ± 0.08   89.90 ± 0.10# 
IC50 3.72 
(R2=0.9308) 
5.19# 
(R2=0.8657) 
3.55 
(R2=0.8606) 
0.78# 
(R2=0.9262) 
#Significantly different (p < 0.05) from the respective control (acarbose). 
 
 
 
Figure 1: Lineweaver-Burk plot of aqueous extract of Cyperus esculentus showing competitive inhibition on the activity of 
α-amylase. Data represent mean ± SEM of three determinations. 
 
 
Sabiu et al., Afr J Tradit Complement Altern Med., (2017) 14 (4): 46-53 
https://doi.org/10.21010/ajtcam.v14i4.6 
 
51 
 
 
Figure 2: Lineweaver-Burk plot of aqueous extract of Cyperus esculentus showing uncompetitive inhibition on the activity 
of α-glucosidase. Data represent mean ± SEM of three determinations 
 
 
Discussion 
 
Of the carbohydrates-metabolizing enzymes, the 𝛼-glucosidase and 𝛼-amylase represent the most crucial of the 
pharmacological targets in the management of DM (Krentz and Bailey, 2005). These enzymes facilitate hydrolysis of starch 
to glucose with consequential increase in the systemic concentration of glucose. This increased hyperglycemia may 
constitute an independent risk factor for the development of microvascular and macrovascular complications of diabetes 
mellitus which is mediated through oxidative stress (Kim et al., 2000). Hence, the inhibition of these enzymes activities 
delays glucose absorption and moderates postprandial blood sugar level (Sabiu and Ashafa, 2016). As presented in this 
study, CEE had significant inhibitory effect on the specific activities of 𝛼-amylase and 𝛼-glucosidase. Judging by the IC50 
values and relative to the standard, it was evident that the extract elicited a stronger inhibition on the activity of 𝛼-
glucosidase than 𝛼-amylase and this is therapeutically significant in abolishing the adverse effects consistent with the 
conventional 𝛼-glucosidase and 𝛼-amylase inhibitors (Sabiu et al., 2016b). The competitively inhibited activity of the α-
amylase is indicative of a stronger structural resemblance of the major constituent of the extract to the substrate which 
facilitated its favourable binding on the active site of the enzyme at the expense of the substrate. By effect, the rate of starch 
hydrolysis to free glucose is either effectively reduced or abolished. Furthermore, the reduced Vmax and Km values for the 
extract (predicting uncompetitive mode of inhibition on the activity of α-glucosidase) may suggest a higher affinity of the 
enzyme for CEE than the substrate, thereby strategically modulating further carbohydrate hydrolysis.  
The relationship between generation of free radicals and the pathogenesis of DM and its complications has been 
demonstrated (Wolff, 1993). In the present study, the extract of CE exhibited significant anti-radical activities as shown by 
its IC50 values when compared with the reference antioxidant used. The closeness of the R2 values to 1.0 is not only 
suggestive of either precision or accurate submissions for all the assays conducted, but also informative of the capability of 
CEE to stall free radicals chain reactions associated with diabetes complications. Besides being consistent with previous in 
vitro studies (Apostolidis et al., 2007; Sabiu et al., 2016b), our assertion also agrees with the report of Mazumdar et al. 
(2009), where plant-derived antioxidants proved effective in treating DM in vivo. 
Overall, the effects elicited by CEE in this study could be ascribed to its minerals and phytonutrients which are 
known for their antidiabetic attributes. Besides containing tannins, alkaloids and saponins [whose antidiabetic potentials in 
aiding regeneration of pancreatic β-cells and inhibition of the specific activities of α-glucosidase and α-amylase have been 
reported (Kunyanga et al., 2011; Zheng et al., 2011; Madhusudhan and Kirankumar, 2015)], previous report on the GCMS 
analysis of CEE also revealed rotundiene (0.87%), taxol (0.32%), camptothecin (1.12%), morphine (1.36%), allicin 
(1.11%), viblastine (5.24%), isokobosone (5.33%), tubocurrarine (5.43%), capscicine (6.79%), p-cymol (7.34%), 
vincristine (7.64%) and digoxigenin (8.11%) as its major adaptogenic constituents (Sabiu et al., 2016a). These compounds 
have been implicated either as ROS scavengers or hypoglycemic agents (Harikesh et al., 2012; Kayarohanam and 
Kavimani, 2015; Sabiu et al., 2016a). 
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Conclusion 
 
The data presented in this study have demonstrated CEE as a tentative novel and potential inhibitor with specific 
and high affinity for carbohydrate hydrolysing enzymes. This was achieved by competitively and uncompetitively 
inhibiting α-amylase and α-glucosidase, respectively, thus modulating the rates of carbohydrate metabolism to glucose. 
While further clinical trials with CEE may be imperative, effort is underway to completely characterize its 
implicated antidiabetic constituent(s). 
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